Plasma prekallikrein may be vascular risk factor in T1DM
(HealthDay)—Plasma prekallikrein (PK) is associated with vascular disease risk in type 1 diabetes, according to a study published online Nov. 24 in Diabetes.
Dec 4, 2015
0
0
(HealthDay)—Plasma prekallikrein (PK) is associated with vascular disease risk in type 1 diabetes, according to a study published online Nov. 24 in Diabetes.
Dec 4, 2015
0
0
A group of researchers led by Mayo Clinic has discovered that disclosing genetic risk for coronary heart disease (CHD) results in lower low-density lipoprotein cholesterol (LDL), also known as bad cholesterol. The findings ...
Nov 9, 2015
0
9
In a study examining the effect of financial incentives to improve lipid levels among patients in primary care practices, shared financial incentives for physicians and patients, but not incentives to physicians or patients ...
Nov 8, 2015
0
5
What's the best way to get heart patients to properly use statins?
Sep 22, 2015
0
10
A simple, low-cost automated program of semi-personalized mobile phone text messages supporting lifestyle change led to improvement in low-density lipoprotein cholesterol (LDL-C) levels, blood pressure, body mass index, and ...
Sep 22, 2015
0
5
Lomitapide (trade name: Lojuxta) has been available since July 2013 as additional treatment for adults with homozygous familial hypercholesterolaemia in whom diet and other drugs do not sufficiently lower cholesterol levels. ...
Sep 17, 2015
0
3
Xian-Cheng Jiang, PhD, professor of cell biology at SUNY Downstate Medical Center, has led a study identifying a new approach for lowering "bad" lipids in blood circulation, a critical means to combat devastating cardiovascular ...
Sep 2, 2015
0
6
(HealthDay)—At lower values of measured low-density lipoprotein cholesterol (LDL-C), the variation and bias of calculated LDL-C increases, according to a study published in the Aug. 15 issue of The American Journal of Cardiology.
Aug 11, 2015
0
11
While undergoing laparoscopic sleeve gastrectomy induced weight loss and improvements in obesity-related disorders, long-term followup shows significant weight regain and a decrease in remission rates of diabetes and, to ...
Aug 5, 2015
0
53
(HealthDay)—For Japanese patients who have undergone percutaneous coronary intervention (PCI), atorvastatin plus ezetimibe is associated with improved outcomes versus atorvastatin alone, according to a study published in ...
Jul 29, 2015
0
10